Copper(II) import and reduction are dependent on His-Met clusters in the extracellular amino terminus of human copper transporter-1.
CTR1
MDCK
SLC31A1
copper homeostasis
polarized epithelia
Journal
The Journal of biological chemistry
ISSN: 1083-351X
Titre abrégé: J Biol Chem
Pays: United States
ID NLM: 2985121R
Informations de publication
Date de publication:
03 2022
03 2022
Historique:
received:
02
08
2021
revised:
12
01
2022
accepted:
14
01
2022
pubmed:
30
1
2022
medline:
16
4
2022
entrez:
29
1
2022
Statut:
ppublish
Résumé
Copper(I) is an essential metal for all life forms. Though Cu(II) is the most abundant and stable state, its reduction to Cu(I) via an unclear mechanism is prerequisite for its bioutilization. In eukaryotes, the copper transporter-1 (CTR1) is the primary high-affinity copper importer, although its mechanism and role in Cu(II) reduction remain uncharacterized. Here we show that extracellular amino-terminus of human CTR1 contains two methionine-histidine clusters and neighboring aspartates that distinctly bind Cu(I) and Cu(II) preceding its import. We determined that hCTR1 localizes at the basolateral membrane of polarized MDCK-II cells and that its endocytosis to Common-Recycling-Endosomes is regulated by reduction of Cu(II) to Cu(I) and subsequent Cu(I) coordination by the methionine cluster. We demonstrate the transient binding of both Cu(II) and Cu(I) during the reduction process is facilitated by aspartates that also act as another crucial determinant of hCTR1 endocytosis. Mutating the first Methionine cluster (
Identifiants
pubmed: 35090891
pii: S0021-9258(22)00071-0
doi: 10.1016/j.jbc.2022.101631
pmc: PMC8867124
pii:
doi:
Substances chimiques
Copper Transporter 1
0
SLC31A1 protein, human
0
Histidine
4QD397987E
Copper
789U1901C5
Methionine
AE28F7PNPL
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
101631Subventions
Organisme : DBT-Wellcome Trust India Alliance
ID : IA/I/16/1/502369
Pays : India
Organisme : Wellcome Trust
ID : IA/I/16/1/502369
Pays : United Kingdom
Informations de copyright
Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Conflict of interest The authors declare that they have no conflicts of interest with the contents of this article.